TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
Women love their hair. They devote time, energy and money to helping it feel and look its best. It’s even a means of self-expression, sometimes more so than a woman’s clothing.
BIOTA Botanicals set out to take the pulse of American women regarding how they really feel about their hair – especially as they (and it) ages.
According to the national consumer survey, most women 30+ have already noticed and worry about the density of their hair as they age. In fact, more women are concerned about thinning-damaged hair than they are about going grey (58% vs. 51%).+ Many say that the condition is embarrassing and a clear-cut sign of getting older, and most agree that it’s an unpreventable fate.
Says Kelli Calabrese, renowned health, beauty and lifestyle expert, “The problem with thinning-damaged hair is not always what’s visible,” she says. “It’s how it rocks a woman’s self-esteem. For women, who put so much emotional value on their hair, it can be absolutely devastating for their self image and emotional well-being.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7598951-biota-fall-beauty-tips/
My mother is almost 90 years and has a hearing loss problem. Her problem started when she was around 70 years. But, most health or physical issues start much earlier. They start from the early twenties or sooner. As you age, your various organs and physical structures start to weaken and deteriorate and become less active. The deterioration rate depends on your emotional and physical health.
Fiber Foods That are Good For You
Fiber is a critical nutrient for your colon and overall health. You need to eat equal amounts of insoluble and soluble fiber. Most people only eat around 8 grams or less of fiber each day. The amount you need to eat is around 25 - 45 grams. This is a lot of fiber and you will need to introduce it slowly into your diet. You may experience gas when you eat more fiber food. But, this will pass as your stomach gets used to eating more fiber.
One reason many people are constipated is they don’t eat a lot of fiber. Most people only eat about 8 mg of fiber per day. To have good health and eliminate constipation, you need around 30- 35 mg of fiber. Eating bran to eliminate constipation is a good start in eating more fiber.
NFL PLAY 60, the National Football League’s youth health and fitness campaign, is the new “Official Champion of Play” at St. Jude Children’s Research Hospital®, the global leader in finding cures and saving children with cancer and other deadly diseases.
To commemorate this new milestone in the ongoing partnership between the NFL and St. Jude, a St. Jude patient will join NFL commissioner Roger Goodell on stage to announce a pick during the first round of the 2013 NFL Draft. The NFL Network and ESPN will televise live coverage of the NFL Draft beginning at 8 p.m. EST on Thursday, April 25.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58566-st-jude-children-s-research-hospital-nfl-play-60
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
Boehringer Ingelheim announced today a new partnership with Minor League Baseball® (MiLB™) to further raise awareness of the rare lung disease idiopathic pulmonary fibrosis (IPF) through its Breathless™ campaign. Now the “Official IPF Awareness Partner of Minor League Baseball,” Boehringer Ingelheim will work with the league to educate its fan base about symptoms of IPF – and the importance of an early diagnosis and treatment – through in-stadium events as well as appearances by New York Yankees legend and musician Bernie Williams, whose father passed away from the disease in 2001.
To view the multimedia release go to:
https://www.multivu.com/players/English/8289951-boehringer-ingelheim-milb-partnership-for-ipf-awareness/
2018 has seen extensive health-focused merger and partnership activity, with nearly 840 deals announced as of Q3. Players new to the industry are driving innovation in the traditionally cautious health and life sciences sectors, with unanticipated and innovative alliances poised to revolutionize health care. McDermott Will & Emery is at the forefront of this activity, helping progressive leaders redefine and navigate the health care landscape through Collaborative Transformations – game-changing partnerships that drive bold and creative business solutions.
To view the multimedia release go to:
https://www.multivu.com/players/English/8207752-mcdermott-innovative-partnership-business-collaborations/
Seqirus announced today that the National Adult and Influenza Immunization Summit (NAIIS) awarded the organization with the 2016 Immunization Excellence Award for best Corporate Campaign. The accolade recognizes Seqirus’ creative and collaborative efforts to improve vaccination awareness and rates during the 2015-16 influenza season. The award was presented yesterday during the NAIIS Summit in Atlanta, Georgia.
“We are pleased to receive this prestigious honor, and thankful to our partners, Families Fighting Flu and several collegiate student organizations, for their dedication to spreading the word about the dangers of flu and encouraging their peers to get vaccinated,” said Dr. Marie Mazur, Vice President of Global Commercial Development and Policy. “Moving forward, Seqirus is committed to building on this season’s success with college students and continuing the important work of flu prevention for all.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7833751-seqirus-national-award-knockoutflu/
Bayer, the maker of Coppertone®, is revolutionizing the sunscreen experience this season with new Coppertone® Whipped, a transformative sunscreen unlike anything you’ve ever felt before. Not only is Coppertone introducing the first ever whipped sunscreen, it is rolling out a series of engaging activations throughout the summer to launch it, and partnering with everyone from beauty influencers to the Skin Cancer Foundation.
The Whipped line, available in both CLEARLYSheer® and WaterBABIES® Pure & Simple formulas, transforms the sunscreen application process from an ordinary task to an experience people can look forward to before they head out into the sunshine. While many other sunscreen lotions can feel heavy or sticky, Whipped has a rich and creamy texture, yet it absorbs quickly and feels light on skin. Plus it won't clog pores and leaves skin feeling soft and smooth while helping to protect it from the sun's harmful UV rays.
To view the multimedia release go to:
https://www.multivu.com/players/English/8113551-coppertone-sunscreen-clearlysheer-whipped/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
